Koneksa Health Revenue and Competitors
Estimated Revenue & Valuation
- Koneksa Health's estimated annual revenue is currently $11.6M per year.
- Koneksa Health's estimated revenue per employee is $102,000
- Koneksa Health's total funding is $70.6M.
Employee Data
- Koneksa Health has 114 Employees.
- Koneksa Health grew their employee count by -2% last year.
Koneksa Health's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | CSO | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | VP, Quality Assurance Compliance and Chief Privacy Officer | Reveal Email/Phone |
5 | VP DevOps and Corporate IT,CISO | Reveal Email/Phone |
6 | VP Sales | Reveal Email/Phone |
7 | General Counsel | Head Corporate Development and Partnerships | Chief Risk Officer | Reveal Email/Phone |
8 | EVP, Product Strategy | Reveal Email/Phone |
9 | EVP Finance | Reveal Email/Phone |
10 | VP, Project Management Office & Special Projects | Reveal Email/Phone |
Koneksa Health Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1760M | 8633 | 7% | $7M | $34.4B |
What Is Koneksa Health?
Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize effect detection in clinical research.
keywords:Pharmaceuticals, Health Care Information Technology, Deep Information Technology, Technology, Clinical Trials, Contract Research Organizations
$70.6M
Total Funding
114
Number of Employees
$11.6M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Koneksa Health News
Pharmaceutical Companies and Research Institutions; Healthcare Providers; Payers ... Ixico plc; Koneksa; Mindstrong Health; Winterlight Labs.
The team at Koneksa Health is developing that possibility right now, and on Monday, announced a $45 million Series C financing round to...
Koneksa, a NYC-based developer of patient-centric digital biomarkers for drug development, closed a $16M Series B financing round. The round was led by Spring Mountain Capital with participation from McKesson Ventures, Novartis Pharma AG and MBX Capital and existing investors Merck Global Healt ...
Koneksa, the leader in developing and implementing patient-centric digital biomarkers for drug development, announced today the completion of a $16M Series B financing round. The company plans to use the investment to expand the development of its digital platform for integrating wearables, sens ...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $28.5M | 114 | 28% | N/A |
#2 | $16.5M | 114 | -34% | N/A |
#3 | $16.5M | 114 | 1% | N/A |
#4 | $18.8M | 114 | -7% | N/A |
#5 | $23M | 114 | 8% | $5M |